Zhaoyong L. Zhang

State Key Laboratory Of Respiratory Disease
Guangzhou, 510182, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Corrigendum to "Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections" [Virol. Sin. 41 (2026) 58-69].

Corrigendum to "Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections" [Virol. Sin. 41 (2026) 58-69].

Journal: Virologica Sinica

Published: June 11, 2026

Roles of lung epithelial stem cells in chronic obstructive pulmonary disease: mechanisms and therapeutic strategies

Roles of lung epithelial stem cells in chronic obstructive pulmonary disease: mechanisms and therapeutic strategies

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses.

Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses.

Journal: Nature communications

Published: September 12, 2025

Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections.

Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections.

Journal: Virologica Sinica

Published: August 26, 2025

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Journal: NPJ vaccines

Published: July 10, 2025

Targeting coronaviral inflammation: aptamer-based strategies for emerging threats.

Targeting coronaviral inflammation: aptamer-based strategies for emerging threats.

Journal: Signal transduction and targeted therapy

Published: May 29, 2025

Development of broadly neutralizing antibodies against Omicron variants from existing neutralizing antibodies in clinical trials.

Development of broadly neutralizing antibodies against Omicron variants from existing neutralizing antibodies in clinical trials.

Journal: Virology journal

Published: March 26, 2025

Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].

Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].

Journal: Antiviral research

Published: March 21, 2025

SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations.

SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations.

Journal: Journal of advanced research

Published: March 03, 2025

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Journal: NPJ vaccines

Published: February 08, 2025

In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models.

In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models.

Journal: Emerging microbes & infections

Published: January 24, 2025

Steric hindrance of antibody binding in an Omicron spike fusion intermediate.

Steric hindrance of antibody binding in an Omicron spike fusion intermediate.

Journal: Nature

Published: January 12, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026